mRNA vaccines: Materials
Materials it needs
The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
Uses- Enz Industrial enzymes criticality low Enzymes copy the mRNA from a DNA template in a cell-free process [2].
- Exc Pharmaceutical excipients criticality medium Lipids form the nanoparticles that protect the mRNA and carry it into cells [3].
- Rgt Reagents and high-purity lab chemicals criticality low The modified RNA building blocks are high-purity specialist chemicals [1].
- Qz Silica sand criticality low Doses are filled into glass vials, and glass is made mainly from silica sand.
as of 2026-11-11. No source gives material amounts per dose; criticality is the writer's judgement. Lipids rank medium because the particles need specialised lipids, a judgement no opened source quantifies.
Critical materials
The materials whose supply could hold it back
- No bulk raw material limits mRNA vaccines; the inputs are small amounts of specialised chemicals and lipids.
- Patents are a smaller barrier than they were: the early mRNA patent claims of 1989 and 1990 had a 17-year term and are now in the public domain [3].
- Cold storage can be a practical constraint on reaching remote places, since the doses must be kept cold from factory to clinic.
as of 2026-11-11
Sources
- Press release: The Nobel Prize in Physiology or Medicine 2023 The Nobel Assembly at Karolinska Institutet, 2023
- mRNA vaccines - a new era in vaccinology Nature Reviews Drug Discovery (N. Pardi, M. J. Hogan, F. W. Porter and D. Weissman), 2018
- The tangled history of mRNA vaccines Nature 597, 318 to 324 (Elie Dolgin), 2021